Logo

Blue Cross and Blue Shield of Kansas City to Cover Combimatrix Dx Services

Nov 12, 2013 | staff reporter

NEW YORK (GenomeWeb News) – Combimatrix said today that Blue Cross and Blue Shield of Kansas City (Blue KC) will cover its diagnostic lab services under a new contract agreement.

The agreement means Combimatrix's suite of testing services and clinical support solutions will be available to Blue KC's more than 800,000 members, Irvine, Calif.-based Combimatrix said. CombiMatrix's diagnostic lab specializes in prenatal, miscarriage, and pediatric testing.

In recent months, Combimatrix has struck coverage agreements with Blue Shield of California, with over 3 million members, and Three Rivers Provider Network, which has more than a million members worldwide, including 15 million in the US.

Filed under

Diagnostics
Invitae
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.